- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEXSEN Aktie jetzt für 0€ handeln | |||||
| 06:10 | Nexsen accelerates global rollout for StrepSure | 1 | The Market Herald Australia | ||
| Mi | NEXSEN LIMITED: Nexsen accelerates global rollout for StrepSure | - | ASX | ||
| So | NEXSEN LIMITED: FDA feedback derisks US approval pathway for StrepSure | - | ASX | ||
| 26.02. | NEXSEN LIMITED: Half Yearly Report and Accounts | - | ASX | ||
| 26.02. | NEXSEN LIMITED: Change in substantial holding - Nexsen | - | ASX | ||
| 24.02. | NEXSEN LIMITED: Nexsen highlights GBS strategy at ISSAD 2026 | - | ASX | ||
| 24.02. | NEXSEN LIMITED: Application for quotation of securities - NXN | - | ASX | ||
| 05.02. | NEXSEN LIMITED: Change in substantial holding - Nexsen | - | ASX | ||
| 05.02. | NEXSEN LIMITED: Application for quotation of securities - NXN | - | ASX | ||
| 29.01. | NEXSEN LIMITED: Quarterly Report - Q2 FY26 | - | ASX | ||
| 26.01. | NEXSEN LIMITED: $500k govt grant expands GBS project to neonates | - | ASX | ||
| 23.01. | NEXSEN LIMITED: Notice under ASX Listing Rule 3.10A | 1 | ASX | ||
| 05.01. | NEXSEN LIMITED: Business Update - FDA engagement underway & key appointment | - | ASX | ||
| 07.12.25 | NEXSEN LIMITED: Investor Presentation | - | ASX | ||
| 05.12.25 | NEXSEN LIMITED: Initial Directors Interest Notice - Kumta | - | ASX | ||
| 02.12.25 | NEXSEN LIMITED: Nexsen Appoints Global Clinical Leader to the Board | - | ASX | ||
| 21.11.25 | NEXSEN LIMITED: Results of AGM | 1 | ASX | ||
| 20.11.25 | NEXSEN LIMITED: Chairman's Address to AGM | - | ASX | ||
| 05.11.25 | NEXSEN LIMITED: Nexsen accelerates US diagnostics market entry | - | ASX | ||
| 31.10.25 | NEXSEN LIMITED: Quarterly Report - Q1 FY26 | 1 | ASX |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 17,660 | -4,85 % | EQS-News: Formycon AG: Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit Regeneron und Bayer | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit... ► Artikel lesen | |
| ONTO INNOVATION | 182,00 | -5,21 % | Onto Innovation stock holds at Stifel on HBM customer win | ||
| KOPIN | 1,842 | -9,62 % | Kopin wins U.S. Phase I SBIR contract for MicroLED display development | ||
| GOMSPACE | 1,428 | -6,79 % | GOMSPACE GROUP AB: GomSpace joins Danish flagship project to unlock next-generation antenna performance for small satellites | ||
| VEECO INSTRUMENTS | 31,400 | -1,88 % | Veeco's revenue down 9.4% year-on-year for Q42025 and 7% for full-year | ||
| XTPL | 15,280 | -3,05 % | EQS-News: XTPL S.A.: XTPL sets issue price of series Y shares at PLN 65.00, offering size to reach PLN 19.5 million | Issuer: XTPL S.A.
/ Key word(s): Capital Increase/Financing
XTPL sets issue price of series Y shares at PLN 65.00, offering size to reach PLN 19.5 million
18.03.2026 /... ► Artikel lesen | |
| GAUZY | 0,910 | +23,64 % | GAUZY LTD: Gauzy Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | TEL AVIV, Israel, March 20, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on March 17... ► Artikel lesen | |
| NANOVIRICIDES | 0,805 | -2,42 % | NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete | SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot... ► Artikel lesen | |
| RIBER | 6,020 | +0,50 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| ZENTEK | 0,510 | +4,51 % | Zentek Ltd.: Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification | Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ACCESS... ► Artikel lesen | |
| DOTZ NANO | 0,018 | -7,89 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| OBDUCAT | 0,003 | -11,76 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 4,260 | 0,00 % | ACACIA RESEARCH CORP - 10-K, Annual Report | ||
| ADVANCE ZINCTEK | 0,450 | -8,91 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.02.2026 | Das Instrument OYS US68162K1060 OLYMPIC STEEL EQUITY wird cum Kapitalmassnahme gehandelt am 16.02.2026 und ex Kapitalmassnahme am 17.02.2026 The instrument OYS US68162K1060 OLYMPIC STEEL EQUITY is traded... ► Artikel lesen | |
| LAMPETIA | 0,094 | -16,81 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen |
Das Unternehmen NEXSEN LIMITED kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSEN LIMITED finden Sie auf Wallstreet Online.